Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    My account
    Logout
AI 90-DAY FORECAST
NEUTRAL SIGNAL
██.█% Sign up free to reveal

Immuneering Corp (IMRX) AI Forecast

Our AI analyzed Immuneering Corp. Create a free account and follow it to see the 90-day price prediction.

✓ Free account • ✓ 30-day free trial

$IMRX Neutral Signal Full forecast available
Sign Up Free

Immuneering Corp (IMRX) Stock Forecast 2025

Immuneering Corp (IMRX) AI Stock Price Forecast & Investment Analysis

Immuneering Corp Stock Price Chart and Technical Analysis

Loading chart...

Immuneering Corp (IMRX) - Comprehensive Stock Analysis & Investment Research

Deep dive into Immuneering Corp's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on August 5, 2026, 3:25 p.m. (UTC)

Immuneering Corp Investment Summary

When evaluating whether Immuneering Corp (IMRX) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Immuneering Corp (IMRX) operates within the Life Sciences sector, specifically in the Pharmaceutical Preparations industry. . With a market capitalization of $285 million, the company is a small-cap stock that may offer higher growth potential but also carries higher volatility.

Financial Performance Analysis

Our comprehensive financial analysis covers Immuneering Corp's revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Immuneering Corp along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Immuneering Corp is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Immuneering Corp

Sign Up Free
Corporate Identity

Immuneering Corp (Stock Symbol: IMRX) is a prominent company operating within the Life Sciences sector, with a specific focus on the Pharmaceutical Preparations industry. The company's shares are publicly traded on the Nasdaq exchange.

Leadership & Workforce

Detailed information about Immuneering Corp's leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Immuneering Corp...

Sector & Industry Analysis

In-depth sector dynamics and industry context for Immuneering Corp...

Unlock Full Company Profile

Get complete details about Immuneering Corp

Sign Up Free
Revenue & Growth Analysis
Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Immuneering Corp...

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Immuneering Corp...

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Immuneering Corp...

Unlock Financial Analysis

Get complete financial metrics for Immuneering Corp

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Immuneering Corp's AI Price Forecast

Join 10,000+ investors using our 67%+ accurate AI predictions

4,000+ Stocks Analyzed
67%+ Accuracy Rate
Daily Updates
Start 30-Day Free Trial →

✓ 30-day free trial • ✓ Cancel anytime

Strategic Market Position

Immuneering Corp strategically competes in the highly dynamic Pharmaceutical Preparations marketplace. As a small-cap company, it represents an emerging market participant with potentially significant growth opportunities. Small-caps often offer greater growth potential as they capture market share and scale their operations, though this comes with higher risk and volatility. Success at this stage can lead to substantial returns for early investors who identify winning business models.

Industry Competitive Landscape

Immuneering Corp competes within the Life Sciences sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency

The company currently shows negative free cash flow of $-50 million . Negative free cash flow may reflect heavy investment in growth, working capital needs, or operational challenges. This is common for high-growth companies investing aggressively but warrants attention for mature businesses.

Margin & Pricing Power Analysis

The company maintains a 48.3% gross margin indicating healthy pricing power relative to direct production costs. This margin level suggests the company has successfully differentiated its products or services, allowing it to command prices meaningfully above input costs. Maintaining these margins requires ongoing investment in brand, technology, or other differentiating factors.

Operating margin of -1010.3% demonstrates how efficiently the company converts revenues into operating profits after accounting for all operating expenses including research and development, sales and marketing, and general administrative costs. Operating margin compression relative to gross margin suggests high operating expenses that may warrant efficiency improvements or reflect necessary growth investments.

Financial Strength & Leverage

Current ratio of 32.45 demonstrates strong short-term liquidity with current assets significantly exceeding current liabilities. This provides a substantial buffer for meeting near-term obligations and handling unexpected financial needs.

Immuneering Corp (IMRX) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Immuneering Corp stock analysis.

Deep dive into Immuneering Corp's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Immuneering Corp stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Immuneering Corp:

P/B Ratio 1.38x
Market Cap $284M
EPS $-11.48
Book Value/Share $3.19
FCF/Share $-0.77
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Immuneering Corp converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Immuneering Corp: An ROE of -27.5% indicates room for improvement in shareholder value creation.

ROE -27.5%
ROA -26.5%
ROIC -27.1%
Gross Margin 48.3%
Operating Margin -1010.3%
Net Margin -1009.6%
EBT Margin -1010.3%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Immuneering Corp's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Immuneering Corp: A current ratio of 32.45 indicates strong liquidity.

Current Ratio 32.45x
D/E Ratio 0.04x
Financial Leverage 1.04x
Working Capital $156M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Immuneering Corp's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Immuneering Corp: Free cash flow of $-50M indicates cash challenges that need attention.

Operating Cash Flow -$50M
Free Cash Flow -$50M
Capital Spending $400K
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Immuneering Corp uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Immuneering Corp:

Payables Period 182 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Immuneering Corp's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Immuneering Corp:

Income Statement
Operating Income -$56M
Net Income -$56M
R&D Expense $50M
Cost of Goods Sold $3M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 161%
Cash & Short-term Investments 47%
Total Liabilities 8%
Short-term Debt 4%
Dividend & Shareholder Information
Shares Outstanding 65M
Growth Metrics (YoY)
Net Income Growth -1009.6%
EPS Growth -260.9%

Latest Immuneering Corp Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Immuneering Corp (IMRX) stock price and investment outlook.

📰 Loading...

Immuneering Corp Competitors & Peer Analysis - Life Sciences Sector

Comparative analysis of Immuneering Corp against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
AARD ██% $158M x 1.8x
ABBV ██% $431.12B 68.3x x
ABCL ██% $1.85B x 2.0x
ABEO ██% $388M 5.9x 2.7x
ABT ██% $183.69B 29.3x 3.5x
ABUS ██% $871M 5.4x 3.4x
ABVC ██% $28M x 2.6x
ABVX ██% $9.83B x x
ACAD ██% $4.64B 12.4x 3.7x
ACET ██% $86M x 0.6x
ACRS ██% $835M x 5.8x
ACRV ██% $60M x 0.6x
ACUT ██% $3M x x
ACXP ██% $6M x 0.9x
ADAG ██% $240M x 6.3x
ADCT ██% $140M x x
ADIL ██% $8M x 2.2x
ADTX ██% $3M x x
ADXN ██% $7M x x
AEON ██% $13M x x
AGIO ██% $1.88B x 1.8x
AKBA ██% $354M x 12.9x
AKTX ██% $14M x 1.0x
ALDX ██% $94M x 2.2x
ALKS ██% $8.32B 125.9x 4.6x
ALLR ██% $21M x 3.0x
ALMS ██% $3.39B x 6.0x
ALNY ██% $29.29B 36.5x 21.6x
ALT ██% $597M x 2.1x
ALXO ██% $265M x 1.8x
ALZN ██% $7M x 9.5x
AMLX ██% $2.43B x 8.9x
AMPH ██% $888M 11.2x 1.2x
AMRN ██% $302M x 0.7x
AMRX ██% $5.84B 47.8x x
ANAB ██% $1.60B x 125.6x
ANEB ██% $13M x 1.7x
ANIP ██% $1.66B 18.0x 3.0x
ANIX ██% $116M x 8.0x
ANNX ██% $812M x 4.0x
ANRO ██% $990M x 4.1x
ANTX ██% $214M x 2.6x
ANVS ██% $80M x 25.5x
APLM ██% $39M x x
APRE ██% $7M x 0.2x
APUS ██% $7M x 0.1x
APVO ██% $5M x 0.4x
AQST ██% $465M x x
ARCT ██% $177M x 0.9x
ARDX ██% $1.24B x 8.3x
ARQT ██% $3.25B x 17.2x
ARTL ██% $3M x 0.4x
ARVN ██% $588M 63.2x 1.0x
ARWR ██% $12.64B x 27.2x
ASBP ██% $9M x 2.4x
ASMB ██% $524M x 2.6x
ASND ██% $15.16B x x
ASRT ██% $151M x 2.0x
ATAI ██% $2.66B x 16.6x
ATHE ██% $80M x x
ATNM ██% $25M x 11.0x
ATOS ██% $23M x 0.8x
ATXI ██% $1M x 1.0x
AUPH ██% $1.95B 6.6x 3.4x
AVBP ██% $1.43B x 4.4x
AVIR ██% $376M x 1.6x
AVTX ██% $980M x 14.4x
AXIM ██% $1M x x
AXSM ██% $10.91B x 199.9x
AZTR ██% $2M x 0.2x
BBIO ██% $16.06B x x
BBOT ██% $710M x 1.9x
BCAX ██% $1.71B x 3.3x
BCTX ██% $29M x 1.2x
BCYC ██% $275M x 0.5x
BDPT ██% $30K x x
BDRX ██% $1M x x
BFRG ██% $11M x 2.3x
BFRI ██% $14M x 2.4x
BHC ██% $2.41B x x
BHST ██% $51M x 2.0x
BIOA ██% $497M x 1.3x
BIOE ██% $13M 9.7x x
BIOM ██% $330K x x
BIVI ██% $14M x 0.9x
BIXT ██% $2M x x
BLRX ██% $12M x x
BLTE ██% $6.19B x 8.0x
BMEA ██% $89M x 4.8x
BMRN ██% $11.74B 43.7x 1.9x
BMY ██% $134.55B 14.5x 6.0x
BNTC ██% $430M x 2.4x
BOLD ██% $61M x 0.7x
BOLT ██% $8M x 0.4x
BPTH ██% $2M x x
BQST ██% $2M x x
BRNS ██% $23M x 0.4x
BSPK ██% $10K x x
BTAI ██% $27M x x
BYSI ██% $41M x x
CALC ██% $13M x x
CANF ██% $7M x 1.2x
CAPR ██% $240M x 0.9x
CATX ██% $342M x 1.0x
CBIO ██% $608M x 6.0x
CDT ██% $2M x x
CING ██% $66M x 3.5x
CLCS ██% $65M x x
CLNN ██% $62M x x
CLRB ██% $20M x 6.1x
CLSDQ ██% $1M x x
CLYM ██% $719M x 4.9x
CMMB ██% $12M x 1.0x
CMND ██% $3M x x
CMPS ██% $1.59B x 4.9x
CNBX ██% N/A x x
CNSP ██% $8M x 110.8x
CNTA ██% $6.27B x 12.9x
CNTB ██% $130M x 3.1x
CNTX ██% $57M x 1.1x
COCP ██% $14M x 3.3x
COGT ██% $7.32B x 12.0x
COLL ██% $1.16B 15.5x 3.7x
CORT ██% $11.57B 209.7x 16.4x
COYA ██% $107M x 2.2x
CPHI ██% $48M x 1.3x
CPIX ██% $116M x 5.4x
CPMD ██% $1M x x
CPRX ██% $3.85B 17.4x 3.8x
CRBP ██% $167M x 1.3x
CRMD ██% $590M 3.3x 1.4x
CRNX ██% $8.87B x 7.4x
CRVO ██% $26M x 2.4x
CRVS ██% $1.17B x 4.9x
CTMX ██% $723M x 2.3x
CTNM ██% $596M x 2.5x
CTOR ██% $61M x 1.7x
CTTH ██% $4M x 5.1x
CTXR ██% $17M x 0.3x
CUE ██% $112M x 5.2x
CURX ██% $6M x 0.7x
CVKD ██% $6M x 3.5x
CVSI ██% $4M x 2.6x
CYCN ██% $15M x 2.9x
CYDY ██% $253M x x
CYPH ██% $73M x 0.9x
CYRX ██% $764M 9.6x 1.5x
CYTK ██% $10.67B x x
DARE ██% $20M x 26.6x
DCOY ██% $2M x 0.6x
DERM ██% $175M x 5.7x
DMAC ██% $352M x 7.5x
DMRA ██% $1.85B x 3.6x
DNTH ██% $6.05B x 5.2x
DRMA ██% $4M x 0.7x
DRUG ██% $759M x x
DSGN ██% $826M x 4.1x
DWTX ██% $60M x 0.7x
DYN ██% $4.85B x 6.9x
EBS ██% $392M x 0.8x
EDSA ██% $48M x 4.7x
ELAB ██% $4M x 0.4x
ELAN ██% $12.78B x 2.0x
ELDN ██% $265M x 5.9x
ELTP ██% $389M 8.7x 3.9x
ELTX ██% $83M x x
ELVN ██% $4.37B x 9.6x
EMMA ██% $700K x x
ENLV ██% $36M 0.0x 0.0x
ENSC ██% $6M x x
ENTA ██% $387M x 3.3x
ENVB ██% $7M x 1.3x
EOLS ██% $403M x x
EPRX ██% $426M x 5.2x
EQ ██% $143M x 2.4x
ERAS ██% $6.38B x 16.2x
ERNA ██% $5M x 0.8x
ESPR ██% $799M x x
ETON ██% $1.25B x 41.0x
ETST ██% $29M 6.0x 4.1x
EVFM ██% $930K x x
EVMN ██% $472M x 1.6x
EWTX ██% $4.80B x 9.7x
FBIO ██% $90M 0.7x 0.6x
FBLG ██% $5M x 1.2x
FBRX ██% $1.57B x 37.3x
FHTX ██% $285M x x
FLNA ██% $48M x 0.7x
FTH ██% $657M x 3.8x
FULC ██% $290M x 0.9x
GALT ██% $197M x x
GANX ██% $75M x 5.3x
GCAN ██% $260K x x
GDTC ██% $10M x x
GENB ██% $1.83B x 3.6x
GERN ██% $875M x 3.8x
GHRS ██% $1.81B x x
GLMD ██% $5M x 0.3x
GLSI ██% $210M x 39.9x
GNLX ██% $126M x 5.5x
GNPX ██% $3M x 0.2x
GOSS ██% $89M x x
GOVX ██% $4M x 2.3x
GPCR ██% $3.53B x 2.4x
GRCE ██% $36M x 0.6x
GRI ██% $3M x 0.3x
GRTX ██% $3.38B 22.7x 4646.0x
GSK ██% $103.20B x x
GTBP ██% $12M x 1.6x
GYRE ██% $686M x 6.8x
HCM ██% $2.01B 2.2x 1.6x
HCWB ██% $6M x 1.0x
HELP ██% $575M x x
HEPA ██% $2M x 0.9x
HIND ██% $15M x 2.3x
HOOK ██% $14M x 0.4x
HOWL ██% $20M x 1.2x
HRMY ██% $2.25B 12.4x 2.3x
HRTX ██% $97M x 10.6x
HSTC ██% $99M x 79.9x
HURA ██% $133M x 5.7x
HYFT ██% $64M x x
HYPD ██% $41M x 0.7x
IBIO ██% $73M x 0.9x
IBO ██% $47M x 4.1x
IDYA ██% $3.48B x 2.9x
IFRX ██% $262M x x
IGC ██% $25M x 4.0x
IMMP ██% $57M x x
IMMX ██% $664M x 7.9x
IMNM ██% $2.84B x 4.8x
IMNN ██% $7M x 2.0x
IMRN ██% $9M x x
IMRX ██% $284M x 1.4x
IMUX ██% $191M x 1.3x
INBP ██% $5M x 0.3x
INDP ██% $181M x 145.2x
INDV ██% $4.34B 14.1x x
INM ██% $8M x 1.2x
INO ██% $68M x 11.2x
INSM ██% $21.38B x 30.3x
INTI ██% $14M x x
INVA ██% $1.54B 3.1x 1.2x
IOBTQ ██% $10K x 0.0x
IONS ██% $9.12B x 20.7x
IRD ██% $306M x x
IRON ██% $2.98B x 4.6x
IRWD ██% $709M 6.9x x
ISCO ██% $2M x x
IVA ██% $1.07B x x
IXHL ██% $36M x 0.5x
JAGX ██% $5M x x
JANX ██% $971M x 1.0x
JAZZ ██% $16.53B 17.6x 3.4x
JBIO ██% $1.30B x 4.4x
JNJ ██% $613.72B 29.2x 7.2x
JUNS ██% $5M x x
KALA ██% $14M x 1.3x
KALV ██% $1.38B x x
KAPA ██% $7M x 1.3x
KAYS ██% $210K x x
KMDA ██% $423M x x
KNSA ██% $5.81B 79.6x 9.6x
KPRX ██% $10M x 0.7x
KPTI ██% $44M x x
KROS ██% $203M x 0.8x
KRRO ██% $164M x 1.4x
KTTA ██% $15M x 0.3x
KURA ██% $841M x 7.8x
KYNB ██% $28M 0.2x x
LAB ██% $320M 4.1x 0.6x
LBRX ██% $1.29B x 3.4x
LEGN ██% $3.70B x x
LEXX ██% $9M x 2.0x
LFCR ██% $163M x x
LFVN ██% $86M 10.9x 2.6x
LGND ██% $6.02B 39.2x 6.0x
LGVN ██% $23M x 1.5x
LIANY ██% $12M x 0.1x
LIFD ██% $3M x 0.4x
LIPO ██% $150K x 0.1x
LITS ██% $33M x 0.6x
LIXT ██% $120M x 15.2x
LKFT ██% $1.74B x x
LLY ██% $997.98B 39.5x 32.0x
LNAI ██% $12M x x
LPCN ██% $18M x 0.8x
LQDA ██% $7.80B 349.9x 71.9x
LRMR ██% $427M x 3.4x
LSTA ██% $10M x 1.0x
LTRN ██% $35M x 10.2x
LXRX ██% $1.06B x 5.2x
LYEL ██% $317M x 1.2x
MAIA ██% $83M x 3.0x
MANE ██% $4.48B x 11.5x
MBIO ██% $4M x 0.5x
MBRX ██% $3M x 0.2x
MBX ██% $3.36B x 7.7x
MCRB ██% $50M x 1.9x
MDCX ██% $17M x 13.0x
MDGL ██% $11.72B x 22.4x
MEDS ██% $8M x 0.1x
MGNX ██% $248M x 11.7x
MIRA ██% $28M x 3.0x
MIRM ██% $6.36B x 26.2x
MIST ██% $138M x 3.8x
MLTX ██% $1.53B x 6.0x
MLYS ██% $2.19B x 3.4x
MNKD ██% $1.22B x x
MNOV ██% $64M x 1.6x
MNPR ██% $794M x 5.9x
MPLT ██% $585M x 1.5x
MREO ██% $51M x 1.5x
MRK ██% $316.42B 35.4x 6.9x
MRKR ██% $21M x 1.5x
MRVI ██% $2.37B x 11.2x
MSLE ██% $209M x x
MTNB ██% $2M x 0.6x
MTVA ██% $8M x 0.8x
NAMS ██% $3.21B x 4.8x
NATR ██% $359M 18.1x 2.2x
NBP ██% $191M x 0.7x
NBTX ██% $1.91B x x
NCEL ██% $19M x 34.3x
NCNA ██% $6M x x
NERV ██% $177M x x
NEUP ██% $21M x 0.7x
NGNE ██% $686M x 2.9x
NIKA ██% $535M x x
NKTR ██% $2.46B x 4.3x
NKTX ██% $168M x 0.6x
NMAD ██% $68M x 8.6x
NNVC ██% $39M x 4.2x
NRIX ██% $2.56B x 6.4x
NRSN ██% $19M x x
NRXP ██% $131M x x
NSRX ██% $41M x 14.8x
NTHI ██% $85M x x
NUVB ██% $2.23B x 7.0x
NUVL ██% $9.75B x 8.3x
NVCT ██% $655M x 72.1x
NVS ██% $292.46B x x
NWBO ██% $257M x x
NXTC ██% $24M x 0.9x
NXTS ██% $3M x 0.2x
OCUL ██% $1.89B x 3.6x
OGEN ██% $2M x 0.4x
OGI ██% $140M x x
OGN ██% $3.56B 17.0x 3.5x
OKUR ██% $166M x 1.0x
OLMA ██% $1.03B x 2.1x
OMER ██% $932M 10.8x x
ONC ██% $33.51B 51.1x 6.5x
ONCO ██% $3M x 0.3x
ONCY ██% $94M x x
OPK ██% $989M x 0.8x
ORGO ██% $305M 112.2x 1.3x
ORIC ██% $1.40B x 3.7x
ORKA ██% $5.92B x 12.2x
ORMP ██% $183M 1.7x 0.8x
OSTX ██% $74M x x
OTLC ██% $18M x 0.1x
OVID ██% $474M x 2.4x
OWPC ██% $110K x x
PAHC ██% $1.48B 15.6x 4.1x
PBH ██% $2.52B 13.2x 1.3x
PBM ██% $12M x x
PBYI ██% $397M 16.3x 3.1x
PCRX ██% $1.10B 75.1x 1.6x
PCSA ██% $6M x 2.2x
PCYN ██% $2M x 1.0x
PDSB ██% $40M x 10.3x
PEPG ██% $133M x 1.0x
PFE ██% $144.81B 33.4x 1.7x
PGEN ██% $2.34B x 53.7x
PHAT ██% $677M x x
PHIO ██% $12M x 0.8x
PHVS ██% $2.37B x x
PKTX ██% $3M x 10.8x
PLRX ██% $65M x 0.4x
PLYX ██% $106M x 42.4x
PMHS ██% $4M x x
PMN ██% $122M x 2.0x
PMVP ██% $62M x 0.7x
PPBT ██% $1M x x
PPCB ██% $2M x 0.2x
PRAX ██% $8.64B x 6.1x
PRFX ██% $3M x 0.4x
PRGO ██% $1.49B x 0.6x
PRLD ██% $373M x 6.2x
PRPH ██% $700K x 0.1x
PRQR ██% $258M x x
PRTA ██% $455M x 1.5x
PTCT ██% $5.76B x x
PTGX ██% $8.72B x 13.3x
PTIX ██% $410K x x
PTN ██% $14M x 1.3x
PTPI ██% $130K 0.0x 0.1x
PULM ██% $6M x 1.7x
PVCT ██% $24M x x
PVLA ██% $2.21B x 10.2x
PYXS ██% $203M x 6.5x
QNRX ██% $9M x 1.0x
QNTM ██% $18M x x
QTTB ██% $480M 14.2x 4.5x
QUCY ██% $34M x 7.4x
QURE ██% $2.75B x 18.4x
RADX ██% $23M x x
RANI ██% $113M x 4.0x
RAPP ██% $2.02B x 4.8x
RARE ██% $2.54B x x
RCKT ██% $375M x 1.6x
RCUS ██% $3.66B x 7.0x
RDY ██% $10.10B x x
REGN ██% $78.20B 18.1x 2.5x
REVB ██% $4M x 0.3x
RFL ██% $97M x 1.3x
RGBP ██% $80K x x
RIGL ██% $778M 2.4x 1.8x
RKTO ██% $20M x 4.9x
RLMD ██% $574M x 2.6x
RLYB ██% $84M x 1.7x
RMHI ██% $25M x x
RMTI ██% $30M x 0.8x
RNAC ██% $230M x x
RNAZ ██% $5M x 3.8x
RNTX ██% $65M x 5.6x
RNXT ██% $47M x 4.2x
ROIV ██% $25.07B x 5.5x
RPRX ██% $33.10B 40.0x 4.8x
RTEZ ██% $1.93B x x
RVPH ██% $7M x 0.4x
RVRC ██% $101M x 16.5x
RYTM ██% $7.28B x 70.7x
RZLT ██% $479M x 4.1x
SBFM ██% $3M x 0.1x
SCNX ██% $15M x 0.2x
SCYX ██% $429M x 10.4x
SDEV ██% $56M 0.1x 0.4x
SDGR ██% $1.16B x 3.7x
SEPN ██% $1.75B x 4.6x
SER ██% $32M x 1.8x
SGMT ██% $493M x 4.8x
SHPH ██% $3M x 0.8x
SIGA ██% $230M 11.4x 1.5x
SILO ██% $5M x 0.9x
SION ██% $2.24B x 7.8x
SKVI ██% $970K x x
SKYE ██% $21M x 2.3x
SLGL ██% $274M x 12.0x
SLN ██% $528M x 10.7x
SLS ██% $2.09B x 19.5x
SMMT ██% $10.80B x 17.2x
SMNR ██% $200M x x
SNDX ██% $1.72B x 114.2x
SNGX ██% $6M x 1.8x
SNSE ██% $31M x x
SNY ██% $102.59B x x
SPRB ██% $128M x 3.7x
SPRC ██% $4M x x
SPRO ██% $73M 4.8x 1.4x
SPRY ██% $539M x 8.8x
SRPT ██% $1.75B 27.0x 1.2x
STOK ██% $2.02B x 5.9x
STTK ██% $737M x 7.7x
SUPN ██% $2.72B x 2.6x
SVRA ██% $1.13B x 6.4x
SXTP ██% $3M x 0.7x
SYBX ██% $13M x 1.1x
SYRE ██% $9.17B x 8.3x
TAK ██% $53.22B x x
TBPH ██% $869M 7.6x 3.0x
TCRT ██% $5M x 3.5x
TELO ██% $84M x 16.9x
TENX ██% $496M x 4.4x
TEVA ██% $40.55B 57.4x 5.2x
TGTX ██% $7.56B 16.4x 13.0x
TLPH ██% $69M x 3.8x
TLX ██% $3.55B x x
TNGX ██% $4.70B x 12.0x
TNXP ██% $180M x 0.8x
TOVX ██% $10M x 0.7x
TPST ██% $14M x 17.6x
TRDA ██% $282M x 1.2x
TRVI ██% $2.38B x 13.8x
TTRX ██% $269M x 44.0x
TVRD ██% $18M x 1.2x
TVTX ██% $5.17B x 52.4x
TXMD ██% $24M 131.9x 0.9x
TYRA ██% $1.94B x 5.0x
UNCY ██% $130M x 3.5x
UPB ██% $367M x 1.2x
URGN ██% $2.16B x x
UTHR ██% $25.91B 20.1x 4.4x
VBIO ██% $1M x 0.1x
VCNX ██% $3M x x
VERA ██% $2.23B x 4.5x
VGLS ██% $240K x x
VICP ██% $47M x x
VKTX ██% $3.88B x 9.5x
VNDA ██% $324M x 1.2x
VRCA ██% $94M x 5.8x
VRDN ██% $2.06B x 3.2x
VREOD ██% $491M x 1.7x
VREOF ██% $491M x 1.7x
VRTX ██% $120.64B 27.8x 6.2x
VSTM ██% $509M x 6.2x
VTGN ██% $11M x 0.3x
VTRS ██% $20.36B x 1.4x
VYNE ██% $19M x 0.8x
WHWK ██% $195M x 1.7x
WVE ██% $1.15B x 2.5x
XBIO ██% $6M x 0.9x
XBIT ██% $69M x 0.5x
XCUR ██% $10M x 4.8x
XENE ██% $6.15B x 4.6x
XERS ██% $1.43B 118.7x 109.6x
XLO ██% $60M x 0.8x
XNCR ██% $1.49B x 2.9x
XOMA ██% $710M 21.0x 7.7x
XTLB ██% $7M x x
ZBIO ██% $1.94B x 5.8x
ZLAB ██% $2.08B x 3.1x
ZNTL ██% $337M x 1.9x
ZTS ██% $31.95B 12.1x 9.9x
ZVRA ██% $608M 4.9x 3.0x
ZVSA ██% $1M x x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Immuneering Corp Stock Forecast

How accurate are Immuneering Corp stock predictions?

Our AI model shows a 3% Spearman correlation coefficient for IMRX predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Immuneering Corp stock price forecasts?

Our analysis considers Immuneering Corp's financial metrics, Life Sciences sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Immuneering Corp a good investment in 2025?

Based on our AI analysis, Immuneering Corp shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Immuneering Corp forecasts updated?

Immuneering Corp stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want a simpler view of Immuneering Corp?

View simplified analysis on AI Stock Finder →

My Portfolio

Investment Dashboard

Loading your portfolio...